Avoid common mistakes on your manuscript.
1 Retraction to: Discover Oncology (2021) 12:57 https://doi.org/10.1007/s12672-021-00453-2
The Editor in Chief has retracted this article. Concerns were raised after publication, and subsequent post publication peer review concluded that there was insufficient experimental work for this article. Therefore, the Editor in Chief has lost confidence in the results of the study. The authors have been offered to submit a revised manuscript for further peer review.
Tsuyoshi Saito, Keita Sasa, Taisei Kurihara, Daisuke Kubota, and Muneaki Ishijima agree to this retraction. Nobuhiko Hasegawa, Kei Sano, Keisuke Akaike, Taketo Okubo, Takuo Hayashi, Tatsuya Takagi, Takashi Yao, and Yoshiyuki Suehara have not responded to any correspondence from the editor about this retraction.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sasa, K., Saito, T., Kurihara, T. et al. Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma. Discov Onc 13, 20 (2022). https://doi.org/10.1007/s12672-022-00481-6
Published:
DOI: https://doi.org/10.1007/s12672-022-00481-6